Flu Vaccine from Nationwidemedical.net

Flu Vaccine

The United States is expected to receive more than 140 million doses for the 2008/2009 season. According to reports, Sanofi Pasteur Inc. is projected to produce 50 million doses, Novartis Vaccines, 40 million doses; GlaxoSmithKline PLC, 35 million does; and CSL Biotherapies, 6 million doses. In addition, MedImmune Vaccines Inc. plans to make about 12 million doses of FluMist. That's a nasal mist containing live virus approved for healthy people between ages 2 and 49. Each year a new vaccine is reformulated based on international surveillance and scientists' estimations about which types and strains of viruses will circulate in a given year.

The 2007/2008 flu season was reportedly the worst in four years for adult deaths of flu and pneumonia. It is recommended by the CDC that anyone in the high risk group or anyone wanting to reduce their risk of getting the flu get vaccinated.

Nationwide Medical will be offering and distributing flu vaccine this upcoming 2008/2009 season. According to the vaccine manufacturers, deliveries are projected to begin towards the end of September.

Inquiries:

Nationwide Medical is eager to help you find flu vaccine. We ask that you provide us with your contact information so that we can respond to your inquiry below. Let us know which product you are interested in and what your needs are. We look forward to working with you!

Title:

Facility Name:*

First Name:*

Address*

Last Name:*

City:*

Company name:*

State:*

Phone Number:*

Extension:

Zip Code:*

Fax Number:

E-mail:*

General Comments:

Please tell us how to contact you... E-mail Phone Fax

Please enter the number on the left.
Refresh the form if the image is not visible or clear.

Key Facts About Seasonal Flu Vaccine
May 5th, 2008

The single best way to protect against the flu is to get vaccinated each year.

There are two types of vaccines:

The "flu shot"— an inactivated vaccine (containing killed virus) that is given with a needle, usually in the arm. The flu shot is approved for use in people older than 6 months, including healthy people and people with chronic medical conditions.
The nasal-spray flu vaccine — a vaccine made with live, weakened flu viruses that do not cause the flu (sometimes called LAIV for “live attenuated influenza vaccine” or FluMist®). LAIV (FluMist®) is approved for use in healthy* people 2-49 years of age† who are not pregnant.

Each vaccine contains three influenza viruses-one A (H3N2) virus, one A (H1N1) virus, and one B virus. The viruses in the vaccine change each year based on international surveillance and scientists' estimations about which types and strains of viruses will circulate in a given year.

About 2 weeks after vaccination, antibodies that provide protection against influenza virus infection develop in the body.